New York City never stops, and as vascular surgeons know, neither do the challenges of calcium. We are very excited to attend VEITH Symposium next week, November 19 – 23, in the Big Apple to discuss the latest IVL updates in vascular intervention. To help you plan your week, we’ve pulled together some of our events that we’re looking forward to most.
Our highlights of the week are going to be our two symposia on Thursday, November 21st. We are honored to have a fantastic panel of IVL experts to discuss how IVL facilitates challenging CLI and EVAR/TEVAR procedures.
RSVP HERE for Simplifying Calcified EVAR/TEVAR Access with IVL.
RSVP HERE for Cracking Critical Limb Ischemia with IVL.
We are also very excited for a presentation by the esteemed Dr. Andrew Holden on what are the right applications for IVL on Wednesday morning, November 20th in Session 24. Here are the details:
Lastly, attend one of our four training sessions in the Endovascular Training Pavilion on Friday to learn more about SFA Intervention for Complex Lesion Management. Here are the details:
If you have a little free time, make sure to admire the autumn foliage of Central Park, walk the Highline in Chelsea, or sip a cold one at the Brooklyn Brewery before you fly back out.
Don’t forget to visit us at our Shockwave booth at VEITH, and if you aren’t already, make sure to follow us on Twitter at @ShockwaveIVL to keep up with the latest news and events.
Contact Us on our website if you have any questions about IVL or if you’d like to setup a time to meet at VEITH.
See you soon!
Important Safety Information
Caution: Federal law (USA) restricts this device to sale by or on the order of a physician.
Indication for Use – The Shockwave Medical Intravascular Lithotripsy (IVL) System is intended for lithotripsy-enhanced balloon dilatation of lesions, including calcified lesions, in the peripheral vasculature, including the iliac, femoral, ilio-femoral, popliteal, infra-popliteal, and renal arteries. Not for use in the coronary or cerebral vasculature.
Contraindications – Do not use if unable to pass 0.014 guidewire across the lesion • Not intended for treatment of in-stent restenosis or in coronary, carotid, or cerebrovascular arteries.
Warnings – Only to be used by physicians who are familiar with interventional vascular procedures • Physicians must be trained prior to use of the device • Use the Generator in accordance with recommended settings as stated in the Operator’s Manual
Precautions – Use only the recommended balloon inflation medium • Appropriate anticoagulant therapy should be administered by the physician • Decision regarding use of distal protection should be made based on physician assessment of treatment lesion morphology
Adverse Effects – Possible adverse effects consistent with standard angioplasty include: • Access site complications • Allergy to contrast or blood thinners • Arterial bypass surgery • Bleeding complications • Death • Fracture of guidewire or device • Hypertension/Hypotension • Infection/sepsis • Placement of a stent • Renal failure • Shock/pulmonary edema • Target vessel stenosis or occlusion • Vascular complications. Risks unique to the device and its use: • Allergy to catheter material(s) • Device malfunction or failure • Excess heat at target site
Prior to use, please reference the Instructions for Use for more information on indications, contraindications, warnings, precautions, and adverse events. www.shockwavemedical.com
